Daily Top 50 Gainers & Losers
cards show the S&P 500's daily move · scroll horizontally → · tracking since Apr 30, 2026
Regime: Risk-On +27
2d · nascent
Viewing
Friday, Jul 17, 2026
Fri
1
7,209
7,229
+0.28%
+1.0
Sat
2
Sun
3
Mon
4
7,230
7,201
-0.40%
-1.1
Tue
5
7,201
7,260
+0.83%
+2.0
Wed
6
7,259
7,366
+1.48%
+2.9
Thu
7
7,365
7,337
-0.38%
-1.1
Fri
8
7,337
7,397
+0.82%
+2.0
Sat
9
Sun
10
Mon
11
7,399
7,413
+0.19%
+0.8
Tue
12
7,413
7,402
-0.15%
-0.6
Wed
13
7,401
7,445
+0.59%
+1.6
Thu
14
7,444
7,502
+0.78%
+1.9
Fri
15
7,501
7,409
-1.23%
-2.3
Sat
16
Sun
17
Mon
18
7,409
7,403
-0.07%
-0.4
Tue
19
7,403
7,355
-0.65%
-1.5
Wed
20
7,354
7,433
+1.08%
+2.3
Thu
21
7,433
7,446
+0.18%
+0.7
Fri
22
7,446
7,474
+0.38%
+1.2
Sat
23
Sun
24
Mon
25
7,446
7,473
+0.37%
+1.2
Tue
26
7,473
7,519
+0.62%
+1.6
Wed
27
7,519
7,521
+0.03%
+0.2
Thu
28
7,520
7,563
+0.57%
+1.6
Fri
29
7,564
7,581
+0.23%
+0.9
Sat
30
Sun
31
Mon
1
7,580
7,600
+0.27%
+0.9
Tue
2
7,600
7,611
+0.14%
+0.6
Wed
3
7,610
7,557
-0.70%
-1.6
Thu
4
7,554
7,585
+0.41%
+1.3
Fri
5
7,580
7,384
-2.59%
-3.7
Sat
6
Sun
7
Mon
8
7,600
7,406
-2.56%
-3.7
Tue
9
7,610
7,387
-2.93%
-4.0
Wed
10
7,554
7,267
-3.80%
-4.7
Thu
11
7,584
7,394
-2.51%
-3.6
Fri
12
7,384
7,431
+0.65%
+1.7
Sat
13
Sun
14
Mon
15
7,406
7,554
+2.01%
+3.5
Tue
16
7,387
7,511
+1.69%
+3.1
Wed
17
7,267
7,420
+2.11%
+3.6
Thu
18
7,394
7,501
+1.44%
+2.8
Fri
19
7,394
7,501
+1.44%
+2.8
Sat
20
Sun
21
Mon
22
7,431
7,473
+0.56%
+1.5
Tue
23
7,554
7,365
-2.50%
-3.6
Wed
24
7,511
7,358
-2.04%
-3.2
Thu
25
7,420
7,357
-0.84%
-1.8
Fri
26
7,501
7,354
-1.95%
-3.1
Sat
27
Sun
28
Mon
29
7,473
7,440
-0.43%
-1.2
Tue
30
7,365
7,499
+1.82%
+3.3
Wed
1
7,358
7,483
+1.70%
+3.2
Thu
2
7,357
7,483
+1.71%
+3.2
Fri
3
7,357
7,483
+1.71%
+3.2
Sat
4
Sun
5
Mon
6
7,354
7,537
+2.49%
+4.1
Tue
7
7,440
7,504
+0.85%
+2.0
Wed
8
7,499
7,483
-0.22%
-0.7
Thu
9
7,483
7,544
+0.81%
+1.9
Fri
10
7,483
7,575
+1.23%
+2.6
Sat
11
Sun
12
Mon
13
7,537
7,515
-0.29%
-0.9
Tue
14
7,504
7,544
+0.53%
+1.5
Wed
15
7,483
7,572
+1.20%
+2.5
Thu
16
7,544
7,534
-0.13%
-0.5
Fri
17
7,575
7,458
-1.55%
-2.6
Sat
18
Sun
19
Mon
20
7,515
7,443
-0.96%
-1.9
Tue
21
7,544
7,509
-0.46%
-1.2
Wed
22
7,572
7,499
-0.97%
-1.9
Thu
23
7,534
7,408
-1.67%
-2.8
Fri
24
7,458
7,412
-0.61%
-1.4
Sat
25
Sun
26
Mon
27
7,443
7,413
-0.40%
-1.1
Tue
28
7,509
7,429
-1.07%
-2.1
Wed
29
7,499
7,316
-2.44%
-3.5
Thu
30
7,408
7,438
+0.40%
+1.2
Fri
31
7,412
7,490
+1.05%
+2.3
Sat
1
Sun
2
Mon
3
7,413
7,601
+2.53%
+4.1
Tue
4
7,429
7,737
+4.14%
+5.6
Wed
5
7,316
7,724
+5.57%
+6.8
Thu
6
7,438
7,710
+3.66%
+5.2
Fri
7
7,490
7,758
+3.58%
+5.1
Sat
8
Sun
9
Mon
10
7,601
7,753
+2.01%
+3.5
Tue
11
7,737
7,728
-0.11%
-0.5
Wed
12
7,724
7,749
+0.32%
+1.1
Thu
13
7,710
7,799
+1.15%
+2.5
Fri
14
7,758
7,786
+0.36%
+1.2
Sat
15
Sun
16
Mon
17
7,753
7,745
-0.10%
-0.5
Tue
18
7,728
7,692
-0.47%
-1.2
Wed
19
7,749
7,708
-0.52%
-1.3
Thu
20
7,799
7,641
-2.02%
-3.1
Fri
21
7,786
7,674
-1.43%
-2.5
Sat
22
Sun
23
Mon
24
7,745
7,653
-1.19%
-2.2
Tue
25
7,692
7,677
-0.19%
-0.7
Wed
26
7,708
7,676
-0.42%
-1.1
Thu
27
7,641
7,731
+1.18%
+2.5
Fri
28
7,674
7,712
+0.49%
+1.4
Sat
29
Sun
30
Mon
31
7,653
7,686
+0.43%
+1.3
Tue
1
7,677
7,631
-0.60%
-1.4
Wed
2
7,676
7,667
-0.12%
-0.5
Thu
3
7,731
7,748
+0.22%
+0.8
Fri
4
7,712
7,719
+0.09%
+0.5
Sat
5
Sun
6
Mon
7
7,712
7,719
+0.09%
+0.5
Tue
8
7,686
7,674
-0.16%
-0.6
Wed
9
7,631
7,636
+0.06%
+0.4
Thu
10
7,667
7,592
-0.98%
-2.0
Fri
11
7,748
7,657
-1.17%
-2.2
Sat
12
Sun
13
Mon
14
7,719
7,620
-1.28%
-2.3
Tue
15
7,674
7,586
-1.14%
-2.2
Wed
16
7,636
7,552
-1.11%
-2.1
Thu
17
7,592
7,638
+0.61%
+1.6
Fri
18
7,657
7,651
-0.08%
-0.4
Sat
19
Sun
20
Mon
21
7,620
7,765
+1.90%
+3.4
Tue
22
7,586
7,765
+2.36%
+3.9
Wed
23
7,552
7,706
+2.04%
+3.6
Thu
24
7,638
7,704
+0.87%
+2.0
Fri
25
7,651
7,743
+1.21%
+2.5
Sat
26
Sun
27
Mon
28
7,765
7,684
-1.04%
-2.0
Tue
29
7,765
7,671
-1.21%
-2.2
Wed
30
7,706
7,652
-0.71%
-1.6
Thu
1
7,704
7,666
-0.49%
-1.2
Fri
2
7,743
7,723
-0.27%
-0.8
Sat
3
Sun
4
Mon
5
7,684
7,774
+1.17%
+2.5
Tue
6
7,671
7,819
+1.93%
+3.4
Wed
7
7,652
7,802
+1.96%
+3.5
Thu
8
Fri
9
Sat
10
Sun
11
Mon
12
Tue
13
Wed
14
Thu
15
Fri
16
Sat
17
Sun
18
Mon
19
Tue
20
Wed
21
Thu
22
Fri
23
Sat
24
Sun
25
Mon
26
Tue
27
Wed
28
Thu
29
Fri
30
Sat
31
Helper Map Key
Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.
Risk-On · supportive
Neutral
Risk-Off · headwind
Stress · fear
Market Recap · Friday, July 17, 2026
Strong Down Day
Fri, Jul 17, 2026 Broad Selloff Normal- 60% Broad selloff across all major indices with NASDAQ-100 down 4.1% and S&P 500 off 1.6%, signaling heavy tech rotation as fear ticked up 9.4% on the VIX; NASDAQ Composite fell 2.9% while small caps held relatively firmer, marking a clear tech-led decline.
- 25% Healthcare sector bucked the trend by dominating both gainers (31% of winners) and losers (31% of losers), suggesting significant internal rotation within the sector as money fled growth names into defensive positioning.
- 15% Five debutant names emerged among gainers (LVLU, AMWL, FMST, CNF, FEIM) signaling fresh money hunting bargains in overlooked corners, while VCIG extended its losing streak to three days as a persistent casualty of the selloff.
Market Regime
Fri, Jul 17, 2026 Neutral conf: low macro · prototype-8
VIX18.8
Drawdown-2.0%
Held9d · established
SinceJul 7
Top drivers:
VIX 5d momentum ▼
S&P drawdown (60d) ▲
S&P 20d return ▼
Market Indexes
Fri, Jul 17, 2026 13
S&P 500
7,457.69
−117.70
-1.55%
Dow Jones
52,146.42
−490.59
-0.93%
NASDAQ Composite
25,520.24
−761.37
-2.90%
NASDAQ 100
28,592.66
−1,232.45
-4.13%
DJ US Total Market
73,903.59
−1,143.56
-1.52%
Russell 1000
4,062.28
−62.93
-1.53%
S&P MidCap 400
3,775.17
−4.94
-0.13%
Russell 2000
2,962.22
−15.59
-0.52%
Russell 2500
1,258.06
−6.69
-0.53%
Russell 3000
4,243.96
−63.89
-1.48%
Nasdaq Financial-100
7,429.63
−8.58
-0.12%
NIFTY 50
24,334.30
+123.30
+0.51%
VIX
18.77
+1.61
+9.38%
Biggest Gainers
Fri, Jul 17, 2026 50About Sadot Group Inc.
Sadot Group Inc. is a diversified food and restaurant company focused on building an integrated presence across the global food supply chain. The company operates a portfolio of restaurant concepts, including Muscle Maker Grill and Pokemoto Hawaiian Poke, as well as non-traditional and hybrid locations that serve a variety of fast-casual and health-oriented meals. In addition, Sadot Group Inc. is involved in meal prep services through SuperFit Foods, targeting consumers seeking convenient, portion-controlled nutrition solutions. Beyond restaurants, the Sadot segment focuses on food supply chain activities, emphasizing sourcing, logistics, and distribution capabilities to support food security and reliable delivery. Headquartered in Burleson, Texas and founded in 1995, Sadot Group Inc. today plays a role in connecting agricultural producers, distributors, and end consumers, serving both retail diners and business partners that rely on stable, efficient food supply solutions.
About Osisko Development Corp.
Osisko Development Corp. is a North American precious metals exploration and development company. Its primary function involves the identification, acquisition, and advancement of gold mining properties, focusing on generating a broad portfolio of quality mining projects. Recognized for its high-potential projects, Osisko Development is noted for its flagship Cariboo Gold Project in British Columbia, a jurisdiction known for its rich mineral history and robust framework supporting mining activities.
Osisko Development Corp. plays a significant role in the exploration sector, working towards transitioning from development into a full-scale gold producer. This positions the company to potentially contribute to global gold supply while fostering economic development in the regions it operates. It caters to the mining industry by focusing on sustainable and innovative mining practices, thereby impacting associated sectors such as metallurgy, engineering, and environmental management.
With its strategic approach, Osisko Development stands out in the market through its commitment to enhancing shareholder value by advancing its mining assets and employing a disciplined financial strategy, thereby underscoring its significance in the competitive landscape of the mining industry.
About Southland Holdings Inc.
Southland Holdings Inc. is a prominent company specializing in infrastructure construction and engineering. With a focus on large-scale projects, the company engages in designing, constructing, and maintaining vital infrastructure such as bridges, highways, tunnels, and water and wastewater treatment facilities. Southland Holdings serves both public and private sector clients, contributing significantly to the transportation and urban development sectors across various regions.
Notable for its expertise in complex civil engineering undertakings, the company is involved in several high-profile and strategic projects that are pivotal to enhancing connectivity and supporting economic growth in the areas it operates. Southland Holdings' work ensures the sustainable and efficient development of modern infrastructure, which is crucial for accommodating the growing needs of cities and communities.
By leveraging advanced technological solutions and adhering to rigorous safety and environmental standards, Southland Holdings Inc. plays a crucial role in the construction industry, impacting various sectors including transportation, urban planning, and utilities management. The company continues to contribute to infrastructure resiliency and modernization, addressing critical needs in both domestic and international markets.
About Callan JMB Inc.
Callan JMB Inc. is an integrative logistics and fulfillment company specializing in thermal management and cold chain solutions for the life sciences and healthcare sectors. Through its subsidiary Coldchain Technology Services, it handles high-value, temperature- and time-sensitive materials such as personalized medicines, cell therapies, vaccines, biologics, diagnostic materials, reproductive tissues, and other frozen biological products. The company provides a vertically integrated ecosystem combining proprietary reusable specialty packaging, warehouse-based fulfillment, cryogenic and frozen shipping, advanced remote monitoring (“Sentry” technology), and technical services designed to safeguard product integrity from origin to end user. Callan JMB also supports emergency management agencies with emergency preparedness and response services, including managing medical stockpiles, building sites, and deployment of critical medical assets in state or local emergencies. Founded in 2006 and headquartered in Spring Branch, Texas, Callan JMB occupies a niche role in the logistics market, enabling compliant, safe, and effective movement of sensitive medical materials while emphasizing regulatory adherence and environmental responsibility in its cold chain operations.
About Baiya International Group Inc.
Baiya International Group Inc. is a holding company that provides technology-enabled human resources solutions in China’s flexible employment market. Through its subsidiary Gongwuyuan, the company operates a cloud-based internet platform delivering one-stop crowdsourcing recruitment and SaaS-enabled HR services to business enterprises and organizations. Baiya International Group Inc. focuses on job matching, entrusted recruitment, project outsourcing, and labor dispatching, helping companies address fluctuating labor demand and specialized staffing needs, particularly in core manufacturing regions such as the Pearl River Delta and Yangtze River Delta. Beyond recruitment, it offers human resource management, payroll processing, electronic contracts and pay slips, HR consulting, labor outsourcing, and staffing and placement services, supported by app development and related internet technology capabilities. Headquartered in Shenzhen, China and founded in 2017, Baiya International Group Inc. serves as a specialized provider within the technology and software application segment of the HR services industry.
About Blueport Acquisition Ltd
Blueport Acquisition Ltd is a blank check company, also known as a special purpose acquisition company (SPAC), incorporated in the Cayman Islands as an exempted company with limited liability. Its primary purpose is to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company has not predefined a specific sector or geographic region for its target search, allowing flexibility in pursuing opportunities across various industries. Founded in 2025 and headquartered at 366 Madison Avenue, 3rd Floor, New York, NY, it is led by experienced executives including Chairperson and CEO William Rosenstadt, a corporate and securities lawyer, and CFO Kulwant Sandher. Blueport Acquisition Ltd completed its initial public offering in November 2025, raising $50 million through 5 million units at $10 each, with units separating into Class A ordinary shares and rights commencing January 6, 2026. As a shell company in the financials sector, it plays a key role in providing public market access to private companies via de-SPAC transactions, operating with zero employees and no current revenues.
About Phoenix Asia Holdings Ltd.
Phoenix Asia Holdings Ltd is an industrials company focused on engineering and construction services in Hong Kong. The firm operates primarily through an indirectly wholly owned operating subsidiary that specializes in substructure works. Its core activities include site formation, ground investigation, and foundation works, which are critical early stages in building and infrastructure development. These services support residential, commercial, and public sector projects by preparing land, assessing ground conditions, and delivering stable structural foundations. In addition to its main substructure operations, Phoenix Asia Holdings Ltd is involved to a lesser extent in other construction services such as structural steelworks, complementing its foundational expertise. Headquartered in Hong Kong, the company plays a role in the regional construction supply chain, serving contractors, developers, and engineering firms that require technically demanding groundwork and structural capabilities in dense urban environments and complex terrain.
About Lulu's Fashion Lounge Holdings, Inc.
Lulu's Fashion Lounge Holdings, Inc. is a dynamic player in the retail fashion industry, primarily operating through its digital platform to offer a curated selection of on-trend apparel, shoes, and accessories for the contemporary woman. The company focuses on delivering chic and affordable fashion through its owned e-commerce website, appealing especially to millennials and Gen Z consumers. Lulu's leverages comprehensive data analytics to refine its product offerings and optimize its supply chain for fast-fashion responsiveness. By emphasizing direct-to-consumer sales, Lulu's minimizes traditional retail overheads and maximizes customer engagement. The company plays a significant role in the digital retail sector, embodying the shift toward online-first shopping experiences and influencing trends in fashion consumption. Known for its ability to quickly adapt to fashion trends, Lulu's Fashion Lounge Holdings, Inc. continually expands its product range, providing a platform for new designers and emerging styles, thereby maintaining its relevance and appeal in the fast-paced world of fashion.
About Semileds Corporation
SemiLEDs Corporation is a semiconductor company that develops, manufactures, and sells light emitting diode chips, components, modules, and systems for global customers. The company focuses on ultra-high brightness LED chips, leveraging proprietary metal alloy vertical chip technology to enhance performance and lumen maintenance. SemiLEDs offers products in blue, white, green, and ultraviolet wavelengths, serving a wide range of general lighting uses, including commercial, industrial, and residential applications. Its LEDs are also used in specialty industrial and professional applications such as ultraviolet curing, medical and cosmetic light therapy, counterfeit detection, germicidal and viricidal devices, horticultural lighting, architectural illumination, and entertainment lighting. SemiLEDs supplies LED chips to packagers, distributors, original design manufacturers, and end users across markets including the United States, Taiwan, the Netherlands, Japan, and other international regions. Incorporated in 2005 and based in Chu-Nan, Taiwan, SemiLEDs plays a niche role in the LED value chain by providing high-performance chips and solutions tailored to demanding and specialized lighting environments.
About Brenmiller Energy Ltd
Brenmiller Energy Ltd. develops, produces, markets, and sells thermal energy storage (TES) systems based on its proprietary and patented technology that enables electrification and decarbonization. It provides bGen TES system that dispatches thermal energy on demand in the form of steam, which can be saturated for industrial use and in the form of superheated steam, which can be used to activate steam turbines. The company also offers power to heat solutions. Its products and solutions are used in Steam, Hot Air, and Thermal Oil applications. Brenmiller Energy Ltd was incorporated in 2012 and is headquartered in Rosh HaAyin, Israel.
About American Well Corporation
American Well Corporation is a prominent player in the telemedicine sector, specializing in the development and deployment of technology-driven healthcare solutions. Its primary purpose is to connect patients with healthcare professionals through video visits, thereby expanding access to medical services and reducing the barriers imposed by traditional, location-based healthcare systems. This corporation provides a platform that facilitates secure and efficient virtual communication between patients and doctors, which is particularly vital in remote or underserved areas. American Well's technology is employed across a variety of healthcare settings, including hospitals, health plans, and employers, striving to enhance the patient experience and improve outcomes. The company plays an essential role in the digital health transformation by leveraging telehealth to meet growing demand for more flexible and accessible healthcare delivery. Established as a leader in the telemedicine industry, American Well's influence extends across both the public and private sectors, underscoring its significance in the ongoing evolution of healthcare services in today's digital age.
About Greenland Mines Ltd
Greenland Mines Ltd is a biotechnology company developing gene therapies for neurodegenerative disorders. Its primary focus is on innovative gene therapy product candidates, including KLTO-101 aimed at the treatment or prevention of Alzheimer’s disease and KLTO-202 for the treatment and prevention of Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis. The company operates in the pharmaceuticals and biotech sector, targeting critical unmet needs in cancer, cardiovascular, and neurodegenerative conditions through advanced cell and gene therapy platforms. Headquartered in Omaha, Nebraska, Greenland Mines Ltd conducts research and development activities centered on these therapeutic areas, positioning it within the broader landscape of emerging biotech firms advancing genetic medicines for severe diseases.
About AmpliTech Group, Inc. Series A Rights
AmpliTech Group, Inc. Series A Rights are subscription rights issued by AmpliTech Group, Inc., a Nevada-based company specializing in radio frequency (RF) microwave components and ORAN 5G network solutions. These rights, traded under the symbol AMPGR, allow holders to purchase additional shares of the company's common stock at a fixed subscription price of $5 per share. They originated from a recent unit offering and received Nasdaq Capital Market listing approval, with trading anticipated to commence on February 3, 2026. Holders must deliver subscription certificates and payment by the expiration date of July 18, 2026, to exercise these rights; unexercised rights will expire worthless thereafter. In the financial markets, Series A Rights serve as a mechanism for AmpliTech Group to raise capital through non-dilutive means initially, enabling existing shareholders to maintain or increase their ownership proportionally. They complement the company's Series B Rights (AMPGZ), which carry a $6 subscription price expiring November 20, 2026, providing structured opportunities tied to the firm's growth in satellite communications, 5G/IoT telecom, defense, space exploration, and quantum computing sectors. These tradable instruments enhance liquidity for rights holders while supporting AmpliTech's expansion in high-performance RF technologies across global markets.
About Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc. is a biotechnology company dedicated to the development of innovative therapies to treat antibiotic-resistant infections. Operating in the healthcare sector, the company focuses on bacteriophage-based solutions, aiming to address the growing global issue of antimicrobial resistance. Armata Pharmaceuticals specializes in researching and developing treatments derived from natural phages, viruses that specifically target and eliminate bacteria, offering an alternative to traditional antibiotics.
The company’s efforts are crucial in fields impacted by resistant bacterial strains, including healthcare-associated infections and chronic illnesses linked to bacterial biofilms. With its headquarters in the United States, Armata engages in collaborations with various research institutions and industry partners, emphasizing a scientific approach alongside cutting-edge technology.
Armata Pharmaceuticals holds a significant position in the biopharmaceutical market, contributing to the advancement of precision medicine and public health innovations. Its dedication to addressing unmet medical needs positions it as a key player in the development of next-generation antimicrobial therapies. By exploring bacteriophage technology, Armata aims to provide targeted, effective alternatives that could revolutionize how infections are managed globally.
About Foremost Clean Energy Ltd.
Foremost Clean Energy Ltd. is a publicly-traded company specializing in the clean energy sector. The company's primary function is to generate and distribute renewable energy solutions, contributing to the global shift away from fossil fuels and towards sustainable energy sources. It plays a significant role in the energy market by focusing on advanced technologies such as solar, wind, and hydropower to provide eco-friendly power options. Foremost Clean Energy Ltd. is pivotal in reducing carbon footprints, thus impacting industries such as utilities, manufacturing, and construction. Its commitment to innovation and sustainability positions the company as a leader in the fight against climate change, influencing policy-making and environmental standards globally. Through its diverse and sustainable energy projects, Foremost Clean Energy Ltd. aligns with increasing environmental regulations and public awareness, highlighting its importance in the market as a reliable source of clean energy solutions.
About Drugs Made In America Acquisition II Corp. Rights
Drugs Made In America Acquisition II Corp. Rights represent a class of financial instruments associated with a special purpose acquisition company (SPAC) incorporated in the Cayman Islands. This blank check company was formed to pursue a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination primarily within the pharmaceutical sector. The rights entitle holders to receive a fractional ordinary share upon consummation of the company's initial business combination. The entity focuses on addressing supply chain risks in the U.S. pharmaceutical industry by investing in companies involved in on-shoring advanced domestic manufacturing technologies for critical drugs. These rights began separate trading on the Nasdaq Global Market under the symbol corresponding to the rights, following the company's $500 million initial public offering of units that included ordinary shares and related rights. The rights play a role in providing investors with opportunities linked to the company’s planned business combination in the pharmaceutical space.
About Cnfinance Holdings Ltd.
Cnfinance Holdings Ltd. operates as a financial services provider in China, primarily focusing on offering home equity loan services to individuals. Its primary function is to serve micro and small-enterprise owners who possess properties but face challenges in accessing traditional financing channels. Cnfinance Holdings' distinctive approach aims to bridge the financing gap by utilizing property as collateral, offering tailored loan products that align with clients' financial needs. By tapping into China's dynamic real estate sector, the company supports the growth and financial stability of small businesses, reflecting broader economic trends and demands.
The company's services are particularly significant in the context of China's evolving financial landscape, where regulatory changes and economic reforms continue to shape the availability and accessibility of credit. Cnfinance Holdings plays a vital role in enhancing financial inclusion, enabling borrowers to leverage their real estate assets effectively. This emphasis on collateralized lending meets the needs of a niche market, positioning the company as a pivotal entity within China's finance and real estate matrix. Its operations highlight the intersection of traditional asset utilization with modern lending solutions.
About Triller Group Inc.
Triller Group Inc. is a U.S.-based digital media and financial services company that operates an artificial intelligence-powered technology platform for creators, consumers, and institutional clients. Its core Triller app functions as a short-form video and social media platform, offering tools for content creation, amplification, and cross-platform distribution, supported by AI-driven engagement, analytics, and marketing solutions. Triller Group also runs live-streaming and combat sports properties, including TrillerTV and Bare Knuckle Fighting Championship, integrating entertainment, influencer events, and pay-per-view programming into its ecosystem. Through its AGBA-branded operations in Hong Kong, the company provides a broad range of financial and healthcare-related services, including wealth management, insurance brokerage, asset management, and lending, delivered via a tech-enabled, multi-channel platform. Founded in 2015 and headquartered in Los Angeles, Triller Group today occupies a hybrid role at the intersection of social media, entertainment, and fintech, serving creators, brands, and retail clients across the United States, Hong Kong, and international markets.
About Enhanced Group Inc.
Enhanced Group Inc. is an elite sports competition and performance products company focused on health, performance, and recovery solutions for athletes and consumers. Headquartered in New York, New York, the company operates across several complementary segments that blend live sports events, performance-focused products, and media. Its core activities include organizing and promoting high-profile athletic competitions designed to showcase peak human performance, and developing products that support training, physical optimization, and post-activity recovery.
Enhanced Group Inc. integrates scientific and technological innovation into its offerings, working at the intersection of sports science, wellness, and entertainment. The company leverages live events, digital platforms, and direct-to-consumer channels to engage athletes, fans, and health-conscious customers. Its media and content initiatives aim to extend the reach of its competitions and brand, creating a connected ecosystem around performance and longevity. Founded in 2023, Enhanced Group Inc. plays a specialized role in the global sports and wellness market by combining competition, consumer products, and immersive audience experiences.
About Frequency Electronics, Inc.
Frequency Electronics, Inc. is a technology company that designs, develops, manufactures, and sells precision time and frequency control products for demanding communication, navigation, and defense applications. Its products support satellite payloads, ground-based telecommunication systems, secure communications, GPS-related technologies, and specialized microwave integrated circuit uses. The company operates through two business segments, FEI-NY and FEI-Zyfer, which together serve commercial, government, and military customers across space and terrestrial markets. Frequency Electronics focuses on high-accuracy timing, synchronization, and frequency generation solutions that are used in systems where stable and reliable signal control is essential. Headquartered in Mitchel Field, New York, the company plays a specialized role in the broader communications equipment industry.
About NextTrip Inc.
NextTrip Inc. is a prominent player in the travel and tourism sector, primarily offering innovative online travel solutions. The company focuses on providing seamless travel experiences by integrating advanced technology into its services. Through its digital platform, NextTrip Inc. enables users to book accommodations, flights, car rentals, and unique travel experiences worldwide. Its offerings target individual travelers, businesses, and travel agencies, seeking to simplify the logistics of travel planning and booking. With a commitment to enhancing the travel experience, NextTrip Inc. continues to adapt to changing consumer preferences by incorporating features like personalized itineraries and virtual travel assistance. The company's role in the market is significant as it caters to the increasing demand for digital transformation in the travel industry, and it supports the growing trend of personalized and flexible travel options. NextTrip Inc. remains positioned at the intersection of technology and travel, striving to make global travel more accessible and efficient.
About Xencor Inc.
Xencor Inc. is a clinical-stage biopharmaceutical company focused on designing and developing engineered antibody therapeutics for cancer, autoimmune disorders, and other serious diseases. The company’s XmAb protein engineering platform is used to create next-generation antibodies and bispecific molecules with tailored biological activity, supporting a portfolio of proprietary and partnered programs in clinical development. Xencor’s work centers on protein engineering that can improve how therapies interact with immune targets and disease pathways, making it a specialized participant in modern antibody drug innovation. The company also collaborates with external partners to apply its platform across multiple therapeutic areas, including oncology and immunology. Headquartered in Pasadena, California, Xencor Inc. operates as a biotechnology company whose current business is built around research, development, and collaboration in advanced biologic medicines.
About Helport AI Ltd.
Helport AI Ltd. is a forward-thinking technology company specializing in artificial intelligence solutions for the logistics and transportation sectors. The company's primary function is to develop and deploy advanced AI-driven platforms that enhance the efficiency and reliability of logistics operations. Their innovative technologies are designed to optimize route planning, automate supply chain management, and improve cargo security through predictive analytics and real-time data processing.
Helport AI Ltd.'s services offer critical insights and automation capabilities to a diverse range of industries, including shipping, air freight, and ground transport. The company's solutions help businesses reduce costs, improve delivery times, and increase overall operational transparency. Situated within the growing AI and transportation sectors, Helport AI Ltd. plays a significant role in driving digital transformation across logistics networks globally.
In the financial market, Helport AI Ltd.'s shares are reflective of the increasing demand for technological advancements in supply chains, offering stakeholders exposure to a rapidly evolving field. As industries move towards embracing AI, Helport AI Ltd. stands out as a pivotal entity in the seamless integration of artificial intelligence into everyday logistics processes.
About Tailwind 2.0 Acquisition Corp. Rights
Tailwind 2.0 Acquisition Corp. Rights represent contractual entitlements issued alongside the Class A ordinary shares of Tailwind 2.0 Acquisition Corp., a special purpose acquisition company formed as a Cayman Islands exempted company. Each right grants the holder the ability to receive one-tenth of a Class A ordinary share upon the successful completion of the company’s initial business combination. These rights are structured to align investor interests with the consummation of a merger or similar transaction, a common feature in blank check company capital structures. Tailwind 2.0 Acquisition Corp. intends to target businesses developing the intelligence layer of energy and compute infrastructure, including areas such as energy routing, compute optimization, and grid intelligence. The rights therefore serve as a supplemental equity-linked instrument tied to the firm’s future combination outcome, providing a defined conversion ratio rather than ongoing cash flows or voting rights prior to conversion. In the broader market for SPAC securities, such rights contribute to the tailored risk–return profiles available to investors participating in early-stage acquisition vehicles.
About ITG, Inc. Class A Common Stock
ITG, Inc. Class A Common Stock represents ownership in ITG, Inc., a provider of end-to-end services for the communications and digital infrastructure industries. ITG focuses on the planning, design, construction, operation, maintenance, and expansion of broadband and related network infrastructure, including fiber routes, aerial and underground builds, conduit installation, and backhaul support. The company also provides engineering, maintenance, and troubleshooting services that help broadband providers, wireless carriers, data center operators, and utility customers build and manage critical connectivity assets. Founded in 2013 and headquartered in Fort Lauderdale, Florida, ITG serves sectors where network reliability, field deployment, and infrastructure modernization are essential. Its business is centered on practical, technology-enabled field services that support the physical backbone of modern communications networks.
About Nextnrg Inc.
NextNRG Inc. is an energy-technology company that focuses on making fueling and power management more efficient for commercial fleets and infrastructure operators. Headquartered in Miami, Florida and founded in 2019, the company integrates mobile fuel delivery, wireless electric vehicle charging, smart microgrids, and battery energy storage into a unified, AI-driven platform. Its services allow customers to schedule on-site fueling and charging, optimize routing and uptime, and better control energy usage across dispersed assets. NextNRG Inc. supports sectors such as transportation, logistics, construction, and utilities, where reliable access to fuel and power is critical for operations. By combining data analytics, software, and physical energy infrastructure, the company plays a role in modernizing how organizations procure, manage, and distribute energy, with an emphasis on operational efficiency and reduced environmental impact.
About Jasper Therapeutics Inc.
Jasper Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for disease treatment, particularly in the field of hematopoietic cell transplantation, autoimmune diseases, and chronic immune disorders. The company's approach relies on targeted technologies aimed at improving the safety and effectiveness of blood and immune system replacement therapies. This is critical in medical procedures like bone marrow transplants where the treatment preconditioning traditionally includes high-dose chemotherapy or radiation, posing significant risks to patients. Jasper Therapeutics strives to provide safer and more effective alternatives, thereby offering a potentially transformative impact on patient outcomes in these sectors. As an entity within the biotechnology industry, its developments have significant implications for healthcare advancements and patient care methodologies. Jasper Therapeutics is strategically positioned within the biotech market, making substantial contributions through its research and development efforts towards better treatment paradigms in its niche areas.
About ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing antibody therapies and therapeutic vaccines that selectively target toxic misfolded proteins in neurodegenerative diseases. Leveraging its proprietary platforms, ProMIS and Collective Coordinates algorithms—along with the advanced EpiSelect™ target discovery engine—the company identifies disease-specific epitopes on misfolded proteins to enable precision treatments. Its lead candidates include PMN310, a monoclonal antibody against toxic oligomers for Alzheimer’s disease; PMN267 for amyotrophic lateral sclerosis; and PMN442 for multiple system atrophy, with additional programs like PMN440 and PMN311 vaccines addressing synucleinopathies and amyloid-beta pathologies. ProMIS Neurosciences also advances therapies for frontotemporal lobar degeneration, Huntington’s disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. Founded in 2004 as Amorfix Life Sciences Ltd. and rebranded in 2015, the company operates from offices in Toronto, Ontario, Canada, and Cambridge, Massachusetts, USA, with a small team of eight employees led by CEO Neil Warma. Operating in the healthcare sector, ProMIS Neurosciences plays a pivotal role in precision medicine for misfolded protein disorders.
About Quhuo Limited
Quhuo Limited, through its subsidiaries, provides workforce operational solutions in the People's Republic of China. It operates in two segments, On-Demand Delivery Solutions and Others. The company offers on-demand delivery solutions for prepared food, grocery, fresh food, and other items for delivery; mobility service solutions, including ride-hailing, shared-bike maintenance, and vehicle export solutions; and housekeeping and accommodation solutions for hotels and B&Bs, as well as other related services. It also provides Quhuo+, a technology infrastructure platform that centralizes operational management and streamline solution processes. The company was founded in 2012 and is based in Beijing, China.
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company focused on developing and commercializing Alpha DaRT, a localized alpha-radiation therapy for solid tumors. The company’s platform is designed to deliver alpha-emitting radiation directly within cancerous tissue, supporting treatment approaches that target tumors while limiting exposure to surrounding healthy tissue. Alpha Tau Medical Ltd. is advancing applications across multiple oncology areas, including skin, oral, pancreatic, prostate, lung, liver, and breast cancers. Its work spans research, clinical development, and potential commercialization, making it a specialist in precision cancer treatment technologies. Headquartered in Jerusalem, Israel, Alpha Tau Medical Ltd. operates in the healthcare and biotechnology sectors and plays a role in the broader market for innovative radiation-based oncology solutions.
About Elite Express Holding Inc.
Elite Express Holding Inc. is a publicly listed company specializing in last-mile delivery solutions for businesses across California, operating within the integrated freight and logistics sector. Established in 2020 and based in Laguna Hills, California, the company focuses on the pickup, secure transportation, and delivery of packages from distribution hubs directly to recipients’ addresses, employing trucks and trailers for logistics. Notable for its use of advanced technologies—such as route optimization platforms—Elite Express Holding Inc. enhances operational efficiency and ensures timely, accurate deliveries. In addition to logistics, the company offers post-delivery feedback systems, enabling real-time shipment tracking and quality assurance through detailed driver performance records. Elite Express Holding Inc. operates primarily through its wholly owned subsidiary, JAR Transportation Inc., reflecting a streamlined corporate structure designed for regulatory compliance and service reliability. By facilitating prompt connections between businesses and customers, Elite Express Holding Inc. plays a significant role in supporting the e-commerce and retail supply chain ecosystem.
About Lucid Group Inc.
Lucid Group Inc. is an American technology and automotive company that designs, develops, manufactures, and sells electric vehicles, electric powertrains, battery systems, and related software. Lucid Group Inc. focuses on premium electric mobility through its current vehicle lineup, which includes the Lucid Air sedan and the Lucid Gravity SUV. The company also builds proprietary in-house software and energy storage systems, integrating them into its vehicles to support performance, efficiency, and digital functionality. In addition to direct sales through retail locations, Lucid Group Inc. offers online purchasing and customer support services, along with Lucid Financial Services. Headquartered in Newark, California, Lucid Group Inc. serves the evolving electric vehicle market and plays a role in the broader transition toward software-defined transportation and advanced battery-powered mobility.
About Sweetgreen Inc. Class A Common Stock
Sweetgreen Inc. Class A Common Stock represents ownership in Sweetgreen, a restaurant company focused on serving fresh, healthy meals through its network of salad and bowl restaurants. Sweetgreen’s menu centers on salads, warm bowls, plates, sides, drinks, and other customizable food and beverage offerings designed for convenience and consistency. The company supports digital ordering through its mobile app and website, alongside in-store dining and pickup options, making it part of the fast-casual dining segment with a strong emphasis on ingredient transparency and plant-forward cuisine. Sweetgreen operates in the U.S. restaurant market and appeals to consumers seeking quick-service meals with an emphasis on freshness, seasonal ingredients, and modern food experiences. As a branded restaurant operator, Sweetgreen plays a visible role in the evolving healthy-eating category within consumer food service.
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, acquiring, and commercializing treatments for rare and underserved diseases. Eton Pharmaceuticals, Inc. offers a commercial portfolio that includes therapies for adrenal insufficiency, severe primary IGF-1 deficiency, Wilson disease, phenylketonuria, homocystinuria, tyrosinemia type 1, and central diabetes insipidus, along with prescription products such as oral suspensions, injectable formulations, and oral solutions. The company also works across pediatric and adult care settings, supporting medications used in endocrine, metabolic, and other niche therapeutic areas. Based in Deer Park, Illinois, Eton Pharmaceuticals, Inc. plays a focused role in the rare-disease market by bringing specialized medicines to patients and healthcare providers through a mix of in-licensed products, commercial launches, and targeted product development.
About Wetour Robotics Limited
Wetour Robotics Limited operates as a physical AI infrastructure and wearable robotics company. The company offers AI driven travel and mobility services under the Wetour brand. It focuses on developing Orchestra, an operating system that coordinates human intent with intelligent physical devices, including wearable robotics. The company was formerly known as Webus International Limited and changed its name to Webus International Limited in March 2026. Wetour Robotics Limited was founded in 2019 and is headquartered in Austin, Texas.
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. is a biotechnology company focused on enhancing the delivery of bioactive compounds, including cannabinoids and nicotine, through its proprietary drug delivery platform, DehydraTECH. The primary function of this platform is to improve the speed and efficiency of oral absorption of active pharmaceutical ingredients, with potential applications extending across a wide range of industries, including pharmaceuticals, nutraceuticals, consumer packaged goods, and more. Lexaria's technology aims to provide alternative product formulations that offer improved bioavailability and taste masking without altering the stimulant properties of the active compounds. By operating at the intersection of drug development and consumer health, the company plays a pivotal role in advancing innovative delivery solutions, contributing to the growing market of next-generation wellness products. Lexaria Bioscience Corp. continues to partner with organizations intent on developing products that integrate its advanced technology, seeking to capitalize on emerging markets where efficient delivery systems for bioactive substances are increasingly in demand.
About Ryde Group Ltd.
Ryde Group Ltd. is a dynamic player in the mobility and transportation services sector, focusing on providing innovative ride-hailing solutions. The company's primary function is to offer efficient, reliable, and user-friendly transport options through its mobile platform. Ryde Group Ltd.'s services are designed to enhance urban mobility, addressing the needs of both individual commuters and businesses seeking to optimize their transportation logistics. The company impacts several key sectors, including urban transport, technology, and logistics, by integrating advanced algorithms and data analytics to streamline services and improve user experience. In the financial market, Ryde Group Ltd. holds significance as a representative of the growing demand for digital and flexible transport solutions typical of urban societies globally. Its technology-driven approach and service-oriented model position it as a competitive entity in the mobility ecosystem, influencing market trends and consumer preferences within the transportation industry.
About Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc. provides comprehensive waste management solutions and environmental services across North America. Its primary function is to offer safe and innovative treatment, storage, and disposal of radioactive and other hazardous wastes. This company plays a critical role in supporting both government and commercial entities, including sectors such as nuclear power, defense, energy, and industrial facilities that require compliant waste processing solutions. Perma-Fix is known for its proprietary technologies and processes, which enable the effective handling of low-level radioactive materials. The company's efforts contribute significantly to environmental preservation by ensuring public safety and adherence to regulatory compliance standards. Founded in 1990, Perma-Fix has established itself as a key player in environmental remediation and waste management, frequently engaging in complex projects such as decommissioning and decontamination of sites. Its services are integral to maintaining environmental health and sustainability, allowing various industries to operate within environmental guidelines and safely manage byproducts of their operations.
About Calisa Acquisition Corp Right
Calisa Acquisition Corp Right is a derivative security issued by Calisa Acquisition Corp, a blank check company structured as a Cayman exempt entity. The primary function of this right is to grant holders the entitlement to receive a portion of an ordinary share—specifically, each right entitles the holder to acquire 0.1 ordinary share upon the successful completion of the company’s initial business combination, such as a merger or acquisition. Calisa Acquisition Corp is focused on identifying and executing a business combination with one or more companies, with a stated emphasis on opportunities throughout Asia. Rights like these are commonly used in the special purpose acquisition company (SPAC) structure to provide investors with added potential value and to enhance the attractiveness of the initial public offering. These rights trade independently from the ordinary shares after separation and represent a contingent claim on future equity, conditional on the company completing a qualifying business transaction within a specified timeframe.
About Xchange Technologies Inc.
Xchange Technologies Inc. is a prominent enterprise specializing in developing financial technology solutions tailored for the modern marketplace. The company's core function is to provide cutting-edge trading platforms and analytical tools that enhance efficiency and accessibility for traders and investors. Xchange Technologies caters to a diverse range of sectors, including banking, brokerage firms, and hedge funds, offering innovative software and systems integration services that facilitate real-time market data processing and algorithmic trading. Beyond its technological prowess, the company focuses on cybersecurity measures and compliance solutions, ensuring that its platforms adhere to regulatory standards and protect consumer data. In today's financial ecosystem, Xchange Technologies holds a vital role by bridging the gap between traditional financial practices and digital advancements, thereby enabling smoother transaction flows and informed decision-making across global markets. The company's solutions are designed to effectively address the demands of a rapidly evolving industry, positioning itself as a trusted ally for organizations striving for digital transformation in the financial sector.
About Estrella Immunopharma Inc.
Estrella Immunopharma Inc. is a biotechnology company dedicated to the research and development of innovative therapies. Primarily focusing on creating advanced treatment options for cancer and other serious diseases, the company harnesses cutting-edge technologies to address unmet medical needs. Estrella Immunopharma operates within the highly impactful biopharmaceutical sector, where its contributions can have significant implications for healthcare treatments globally. With a commitment to scientific excellence, the company engages in the discovery of novel drug candidates, advancing them through rigorous clinical trials. Estrella Immunopharma is pivotal in translating scientific innovations into viable medical solutions, contributing to the growing field of personalized medicine. Its role in the market is significant, given the increasing demand for targeted therapies and advancements in medical technology. As a part of the pharmaceutical industry, it not only influences healthcare advancements but also impacts clinical practices, offering potential pathways to improve patient outcomes through novel and effective treatment modalities.
About Alto Ingredients Inc.
Alto Ingredients Inc. is a leading producer and distributor of specialty alcohols, renewable fuels, and essential ingredients. The company operates through three main segments: Marketing and Distribution, which handles marketing and merchant trading of company-produced alcohols, essential ingredients, and third-party fuel-grade ethanol; Pekin Campus Production, focused on producing and selling alcohols and essential ingredients at its Pekin, Illinois facility; and Western Production, covering renewable fuel and essential ingredients from two western U.S. facilities. Alto Ingredients Inc. serves diverse markets including Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels, supplying customers such as food and beverage companies, consumer products manufacturers, and distributors. Its products enhance everyday goods like cleaning solutions, pharmaceuticals, high-protein feeds, pet food, and low-carbon ethanol fuel. Founded in 2003 and headquartered in Pekin, Illinois, Alto Ingredients Inc. leverages its ethanol production capabilities across five U.S. facilities to meet demand in these key sectors.
About Alps Group Inc.
Alps Group Inc. is a biotechnology and life sciences company headquartered in Kuala Lumpur, Malaysia. It operates as a fully integrated platform that encompasses biotechnology research, medical services, and wellness solutions, with a specialization in predictive, precision, and preventive health management. Through its subsidiaries, the company provides research and development for advanced therapies, including access to DNA and mRNA sequencing, cellular therapy, and anti-aging products and services. Alps Group Inc. focuses on delivering innovative wellness solutions and medical services tailored to clientele seeking cutting-edge health interventions. Its operations span the biotechnology sector, contributing to advancements in personalized medicine and life sciences applications across regional markets.
About SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company focused on developing novel therapies for cancer. SELLAS Life Sciences Group, Inc. concentrates on immunotherapeutic and targeted oncology programs designed to address a broad range of hematologic and solid tumor indications. Its current pipeline includes product candidates aimed at cancers such as acute myeloid leukemia, reflecting its emphasis on disease areas with significant unmet medical need. The company’s work centers on advancing clinical-stage assets through research and development, with a business model built around innovative cancer treatment platforms rather than commercialized consumer products. Headquartered in New York, SELLAS Life Sciences Group, Inc. plays a role in the biotechnology market as a specialist developer of experimental oncology therapies.
About Cue Biopharma, Inc.
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing a novel class of injectable biologics. These engineered therapies are designed to selectively engage and modulate targeted T cells, mimicking nature's signals to expand and activate specific immune cells while restoring immune balance. The company's platform addresses serious diseases by mobilizing the patient's own immune system for precise therapeutic responses. Operating within the biotechnology industry and pharmaceuticals & biotech sector, Cue Biopharma, Inc. advances its programs through clinical development, emphasizing innovative biologics that offer potential in immunotherapy applications. Founded in 2014 and headquartered in Boston, Massachusetts, the company concentrates on creating targeted treatments that harness immune mechanisms to combat disease, positioning it as a key player in the evolving landscape of immune-oncology and related therapeutic areas.
About Netclass Technology Inc.
Netclass Technology Inc. is a technology services company that operates as a holding entity focused on business-to-business smart education solutions. The company provides integrated IT systems to schools, training institutions, corporations, public agencies, and other organizations, with an emphasis on digitizing teaching and administrative workflows. Its offerings span teaching management platforms, campus management systems, online teaching and examination tools, and lecturer evaluation services, enabling clients to manage learning processes and performance in a centralized, data-driven manner. Netclass Technology Inc. also supports specialized functions such as epidemic prevention and control management and an education credit blockchain system designed to securely record and verify academic credentials. By delivering these packaged software and platform-based services, the company plays a role in the modernization of education and training infrastructure, particularly for institutional and corporate customers seeking scalable, cloud-enabled learning and campus management solutions. Founded in 2022 and headquartered in Shanghai, China, Netclass Technology Inc. operates within the broader technology services and packaged software segment of the global education technology market.
About Geovax Labs Inc.
GeoVax Labs Inc. is a clinical-stage biotechnology company specializing in the development of human vaccines and immunotherapies. Headquartered in Smyrna, Georgia and founded in 1988, the company focuses on addressing unmet medical needs in infectious diseases and oncology. GeoVax Labs Inc. leverages proprietary vaccine platforms to develop preventive vaccines against high-consequence pathogens, including hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, as well as Zika virus, malaria, and human immunodeficiency virus (HIV). In addition, the company is advancing therapeutic candidates targeting solid tumor cancers, using gene-directed and immune-activating approaches to enhance antitumor responses. Its pipeline includes next-generation vaccine candidates and cancer immunotherapies that are evaluated through clinical and preclinical programs. Operating within the broader biotechnology and health technology sectors, GeoVax Labs Inc. plays a specialized role in the market by focusing on complex, often neglected disease areas where robust immune protection or targeted immunotherapy can be particularly important for public health and clinical practice.
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics that target fundamental biological pathways of cancer. It maintains a broad pipeline of product candidates, with an initial emphasis on validated oncology targets designed to address large patient populations. The company advances innovative therapies, including a first-in-class WEE1 inhibitor in late-stage development and biomarker-driven treatments for ovarian cancer. Zentalis Pharmaceuticals, Inc. operates within the health technology and biotechnology sectors, contributing to oncology research by pursuing small molecule approaches to improve cancer treatment options. Founded in 2014 and headquartered in San Diego, California, it dedicates efforts to groundbreaking research in clinical-stage oncology programs.
About Green Plains Inc.
Green Plains Inc. is a biorefining and agricultural processing company that turns annually renewable crops into low-carbon fuels and sustainable ingredients. Green Plains produces ethanol and related co-products, including distillers grains, ultra-high protein feed ingredients, and renewable corn oil, while also handling grain procurement, storage, merchandising, and energy services. Its operations are organized around ethanol production and agribusiness activities that support the movement and commercialization of agricultural commodities. The company serves fuel, feed, and industrial markets by applying fermentation and agritech processes to corn and other grains. Headquartered in Omaha, Nebraska, Green Plains Inc. is positioned as a diversified supplier within the renewable fuels and value-added ingredients market.
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing monoclonal antibody therapies for psoriasis and other inflammatory and immunology-related conditions. Its current pipeline centers on treatments designed to target key pathways involved in immune-mediated skin and joint diseases, including plaque psoriasis, psoriatic arthritis, and hidradenitis suppurativa. The company’s lead programs include ORKA-001, which targets the interleukin-23 p19 subunit, and ORKA-002, which targets interleukin-17A and interleukin-17F. Oruka Therapeutics is also advancing additional programs and combination regimens intended to broaden its dermatology and immunology portfolio. Headquartered in Menlo Park, California, Oruka Therapeutics plays a role in the biotech sector by developing targeted biologic medicines for chronic inflammatory diseases.
Biggest Losers
Fri, Jul 17, 2026 50About Vivakor Inc.
Vivakor Inc. is a multifaceted company that focuses primarily on the development and commercialization of clean energy technologies. This asset stands at the intersection of environmental sustainability and technological innovation, offering solutions that aim to reduce carbon emissions and promote resource efficiency. Vivakor's operations often impact the energy and environmental remediation sectors, where the company seeks to establish scalable and economically viable projects. One notable feature of Vivakor is its contribution to the oil reclamation industry, particularly through the deployment of advanced extraction and cleaning processes that retrieve usable oil from contaminated sources. This approach not only aids in environmental conservation but also enhances energy resource management. In the financial markets, Vivakor Inc. plays a significant role by addressing the growing demand for sustainable practices within the energy sector, appealing to stakeholders interested in renewable and clean energy solutions.
About Stak Inc.
Stak Inc. is a holding company principally engaged in the research, development, manufacturing, and sale of oilfield-specialized production and maintenance equipment. It designs and manufactures specialized equipment for oilfield operations, collaborating with qualified vehicle manufacturers to integrate this equipment onto chassis, producing vehicles such as oil pumping trucks, oil-well repair trucks, fracking trucks, well flushing-wax removal trucks, and boiler trucks. The company also sells equipment components, related products, and provides automation solutions aimed at enhancing efficiency, energy savings, and environmental performance in oilfield services. Stak Inc. operates within the oil and gas equipment and services industry, serving oilfield service companies with integrated solutions for production, repair, maintenance, fracking, cleaning, wax removal, pumping, and boiler operations. Founded in 2020 and headquartered in Changzhou, Jiangsu, China, Stak Inc. focuses on niche markets for specialized oilfield vehicles and equipment.
About Nuburu Inc.
Nuburu Inc. is a company that specializes in the development and manufacturing of high-power blue laser technology. Primarily used within sectors like aerospace, automotive, and electronic manufacturing, the company’s innovative laser solutions enhance precision in metal processing. The blue laser technology allows for more efficient and precise cutting and welding processes compared to traditional laser systems, significantly impacting industries that require high precision, such as battery manufacturing and 3D printing. By providing advanced materials processing capabilities, Nuburu Inc. plays a pivotal role in advancing manufacturing technology, contributing to improved productivity and reduced production costs within these industrial sectors. Founded with a focus on revolutionizing laser applications, Nuburu Inc. remains a key player in the technological expansion of industrial manufacturing processes, optimizing them through innovative applications of its blue laser technology.
About Cycurion Inc.
Cycurion Inc. is a technology-enabled cybersecurity and information technology services company based in McLean, Virginia. It focuses on providing tailored IT security solutions to organizations across governmental and commercial markets in the United States. Cycurion Inc. delivers a broad range of consulting and advisory services, including security control assessments, security architecture and engineering, risk management and compliance, cloud security, virtual CISO support, and cybersecurity awareness and training. The company also offers managed IT services such as network infrastructure management, systems engineering and administration, voice and data infrastructure, application development, and help desk support. Through its subsidiaries, Cycurion Inc. provides network communications, information assurance, and specialized solutions in areas like electronic and information warfare, serving federal, state, and local government agencies as well as corporate clients in sectors including healthcare and other regulated industries. Founded in 2017 and headquartered in McLean, Virginia, Cycurion Inc. occupies a niche within the information technology services industry by combining advisory consulting, managed security services, and software-as-a-service cybersecurity tools to address complex organizational security and IT needs.
About The GrowHub Limited
The GrowHub Limited is a Singapore-based technology company specializing in product traceability, authenticity, and carbon-related solutions for modern supply chains. The company operates primarily through the GrowHub Platform, a Software-as-a-Service offering that leverages technologies such as blockchain and data analytics to help organizations verify product origin, combat counterfeiting, and manage carbon-related information across the value chain. Its platform includes dedicated traceability, anti-counterfeit, and carbon management solutions tailored to industries where product integrity and sustainability are critical, with a particular focus on the food and broader supply chain ecosystem. In addition to its technology platform, The GrowHub Limited provides IT consultancy and software development services, supporting clients in implementing and integrating these digital infrastructure tools. The company also engages in product trading facilitation, helping brands place products in retail and online channels and enabling bulk wholesale transactions. From its base in Singapore, The GrowHub Limited serves organizations ranging from start-ups to large enterprises across the Asia-Pacific region.
About Cloudastructure Inc.
Cloudastructure Inc. provides cloud-based artificial intelligence video surveillance and remote guarding services built on AI and machine learning platforms. The company offers cloud video surveillance that stores footage in the cloud with computer vision features including face recognition, license plate reading, object detection, and anomaly identification. Its remote guarding solution includes browser-based call center software connecting to live agents for real-time threat response via audio deterrence and escalation. Complementary products encompass cloud video recorders for IoT video collection and transmission, cameras, speakers, mobile surveillance trailers powered by solar and battery with wireless broadband, and smart parking solutions. Cloudastructure Inc. serves enterprise customers in multifamily property management, commercial real estate, construction, logistics, retail, transportation, and workforce housing, enabling centralized security management across multiple locations with hardware-agnostic, scalable architecture. Incorporated in 2003 and headquartered in Palo Alto, California, it operates a global guard center to support proactive security monitoring.
About GraniteShares 2x Long Intuitive Surgical, Inc. (ISRG) ETF
GraniteShares 2x Long Intuitive Surgical, Inc. (ISRG) ETF is a leveraged exchange-traded fund designed to deliver daily investment results, before fees and expenses, that correspond to two times (200%) the daily percentage change of the common stock of Intuitive Surgical, Inc. This ETF primarily achieves its exposure through swap agreements with major financial institutions, supplemented by options contracts or direct purchases of the underlying stock when necessary, while maintaining approximately 200% notional exposure to ISRG at the end of each trading day. Cash balances are invested in U.S. Government securities, money market funds, short-term bond ETFs, or other collateral instruments to support these derivatives. Launched in 2025 and headquartered in New York, New York, the fund concentrates its investment exposure in the smart medical devices industry, making it suitable as a short-term trading vehicle for investors seeking amplified daily performance tied to Intuitive Surgical's stock movements in the healthcare robotics sector.
About Agape ATP Corporation
Agape ATP Corporation is an investment holding company that supplies health and wellness products and health solution advisory services primarily in Malaysia. It operates through two main segments: skin care, health, and wellness, and green energy. In the health and wellness division, the company offers programs such as the ATP Zeta Health Program and E.A.T.S., which include ionized and high bioavailability nutrients for enhanced cellular absorption, energized mineral concentrates, soy protein isolate powder, and LIVO5. It also promotes wellness lifestyles through online editorials, programs, events, campaigns, and health therapies. The green energy segment provides renewable energy products, technical solutions, installations, and maintenance services, focusing on sustainability, energy savings, and environmental stewardship. Agape ATP Corporation was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia, blending health innovations with renewable energy to support wellness and sustainable living.
About Rubico Inc.
Rubico Inc. is an international shipping company specializing in the ownership and operation of eco-conscious tanker vessels for crude oil transportation. The company manages a fleet of two modern, fuel-efficient Suezmax tankers, each approximately 157,000 deadweight tons, designed with advanced technologies to enhance fuel efficiency and reduce greenhouse gas emissions. These vessels operate under medium- to long-term time charter agreements, providing stable employment in the global crude oil shipping market within the energy sector's oil and gas storage and transportation industry. Rubico Inc. employs sale and leaseback financing structures to support its fleet operations, emphasizing operational reliability and environmental performance. Incorporated in the Republic of the Marshall Islands and headquartered with executive offices in Athens, Greece, Rubico Inc. serves as a focused provider of shipping transportation services, catering to charterers in the international tanker market.
About Eureka Acquisition Corp. Rights
Eureka Acquisition Corp. Rights represent a type of derivative security associated with the acquisition of shares in the corresponding special purpose acquisition company (SPAC). The primary function of these rights is to give holders an entitlement to acquire a fraction of a share of the SPAC's common stock post-merger. SPACs like Eureka Acquisition Corp. are formed to raise capital through an IPO for the purpose of acquiring an operational company. Rights are an important feature as they provide additional incentives for investors by potentially increasing their equity stake upon the successful completion of an acquisition. In the broader financial market, SPAC rights are a tool for investors who are interested in the speculative growth opportunities associated with private companies becoming publicly traded entities through mergers.
About Sobr Safe Inc.
Sobr Safe Inc. is a technology company specializing in non-invasive alcohol detection and identity verification solutions. The firm develops hardware and software that use advanced transdermal, touch-based sensing to detect the presence of alcohol through a person’s skin, removing the need for traditional breath, blood, or urine testing. Its core products include SOBRcheck, a stationary device for identification and alcohol monitoring, and SOBRsure, a wearable band designed for continuous, real-time monitoring. These devices are integrated with the SOBRsafe software platform, which provides biometric identity verification, cloud-based alerts, and detailed reporting to enterprise and institutional customers. Sobr Safe Inc. primarily serves markets such as workplace safety and compliance, behavioral health, judicial and family law settings, fleet and facility management, alcohol rehabilitation, and youth driver monitoring. Headquartered in Greenwood Village, Colorado and founded in 2004, the company operates mainly in North America, offering its solutions through channel partners, sales agents, and digital enterprise and consumer channels.
About Schwab Ariel ESG ETF
The Schwab Ariel ESG ETF is an exchange-traded fund designed to reflect a diverse selection of companies that adhere to stringent Environmental, Social, and Governance criteria. Its primary function is to enable investors to align their investment choices with ethical standards focused on sustainability and corporate responsibility. This fund emphasizes the integration of ESG factors into the investment process, aiming to ensure that the selected companies exhibit strong corporate governance, environmental stewardship, and positive social impact. The Schwab Ariel ESG ETF spans various sectors and industries, promoting diversification while adhering to a core philosophy of responsible investment. Its presence in the market represents the growing trend among investors seeking not only financial returns but also supporting broad-based social and environmental objectives, thereby catering to an increasingly conscientious investor base looking to make a meaningful difference through their investment choices.
About JX Luxventure Group Inc.
JX Luxventure Group Inc. is a diversified company focused on tourism-related products, technology services, and cross-border merchandise. JX Luxventure Group Inc. develops and distributes casual menswear while also providing internet-based product services and e-commerce solutions for the travel sector. Its tourism products segment supports online and offline transactions tied to flights, hotels, and destination services, linking consumer travel demand with business partners in China. The technology segment complements these activities with digital tools and service support, while the cross-border merchandise business connects international trade flows across markets. JX Luxventure Group Inc. operates at the intersection of apparel, tourism, and commerce, making it a multi-segment participant in consumer and business services with a role in facilitating both retail distribution and travel-related commerce.
About Jet.AI Inc.
Jet.AI Inc. is a technology-driven company focused on artificial intelligence infrastructure and industry-specific software solutions. The firm develops and secures AI data center sites across North America, concentrating on shovel-ready land and powered campus preparation to support high-performance GPU computing and AI cloud workloads. In parallel, Jet.AI deploys AI-powered tools originally built for private aviation, including platforms that use natural language processing and machine learning to streamline private jet booking, pricing, and operational efficiency for charter operators. These software products address quoting, fleet utilization, emissions tracking, and carbon crediting, as well as management and brokerage workflows for aviation providers. Through this combination of data center infrastructure development and specialized AI software, Jet.AI Inc. serves enterprises that require scalable compute capacity and intelligent applications for complex, logistics-intensive environments. Founded in 2018 and headquartered in Las Vegas, Nevada, the company occupies a niche at the intersection of AI infrastructure and vertical market software, particularly within the private aviation sector.
About Apolomics Inc.
Listed in this day's movers as “Apollomics, Inc.” — the company profile carries a different name (rename, or the ticker changed hands). The read below follows the profile.
Apolomics Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies. It specializes in innovative product candidates designed to harness the immune system and target specific molecular pathways to inhibit cancer, with potential for combination with other treatment options. The company's pipeline includes late-stage clinical assets such as vebreltinib (APL-101), a potent, selective c-Met inhibitor for non-small cell lung cancer and other advanced tumors with c-Met alterations, currently in Phase 2 trials, and uproleselan (APL-106), an E-Selectin antagonist for use with chemotherapy in acute myeloid leukemia and hematologic cancers, in Phase 1 and Phase 3 trials in China. Additional candidates like APL-102, a multiple tyrosine kinase inhibitor, are in early clinical stages. Apolomics Inc. addresses unmet medical needs in difficult-to-treat cancers through its broad portfolio across multiple oncology programs. Founded in 2015 and headquartered in Foster City, California, with operations extending to Taipei, Taiwan, the company operates under the guidance of experienced leadership in biotechnology and pharmaceuticals.
About Laser Photonics Corporation
Laser Photonics Corporation is an industrial technology company that designs and manufactures photonics-based laser systems for material processing applications. The firm focuses on laser cleaning technologies intended to replace or reduce the use of traditional abrasive blasting methods in industrial environments. Its product portfolio includes laser cleaning systems for corrosion control, rust removal, de-coating, pre-weld and post-weld treatment, as well as solutions for surface conditioning and general laser cleaning.
Beyond cleaning, Laser Photonics Corporation offers laser cutting, welding, marking, and engraving systems, including fiber and CO2 cutting platforms, handheld and robotic welding units, and portable and fixed marking and engraving tools. These solutions serve a wide range of sectors, including automotive, aerospace, maritime, nuclear, defense, space, semiconductors, and energy, where precision, process efficiency, and reduced environmental impact are important. Incorporated in 2019 and headquartered in Orlando, Florida, Laser Photonics Corporation operates as a vertically integrated manufacturer and research hub, providing turnkey laser systems and related technologies for industrial customers worldwide.
About Global Mofy AI Ltd.
Global Mofy AI Ltd. is a technology solutions provider focused on virtual content production and digital asset development for the digital content and metaverse industries. The company leverages its proprietary Mofy Lab platform, which integrates three-dimensional reconstruction and artificial intelligence interactive technologies to create high-definition virtual versions of physical world objects, including humans, animals, products, and environments. These digital assets are used across movies, television series, animation, advertising, gaming, AR/VR, and broader immersive experiences. Global Mofy AI Ltd. also offers virtual technology services and related digital marketing solutions, providing end-to-end support from asset creation to content delivery for media, entertainment, and brand clients. The company operates primarily through its virtual technology services and digital asset development segments, reflecting growing demand for AI-enabled content workflows in visual effects and metaverse-related applications. Founded in 2021 and headquartered in Beijing, China, Global Mofy AI Ltd. serves both domestic and international customers in the broader digital content ecosystem.
WYHG
Wing Yip Food Holdings Group Limited American Depositary SharesConsumer Defensive
$3.80−$0.83
-17.9%
About Wing Yip Food China Holdings Ltd.
Wing Yip Food China Holdings Ltd. is a company engaged in the production and distribution of food products in China. The company's primary function is to provide a diverse array of food and beverage items, catering to the dynamic consumer tastes within the Chinese market. This includes an assortment of packaged foods, delicacies, and possibly beverages, though specifics of their product line could vary.
Wing Yip Food China Holdings plays a vital role in the food sector by meeting the demand for quality food products, aided by its strategic positioning within a market known for its rapid economic growth and evolving consumer preferences. The company's activities are crucial in delivering both traditional and modern culinary experiences to customers, potentially influencing dietary trends and food consumption patterns in China.
Given its operations, Wing Yip Food China Holdings contributes significantly to local economies by providing employment opportunities and supporting the supply chain involved in food production and distribution. Its impact extends to both urban and rural communities, highlighting the company’s importance in the broader economic and cultural landscape of the region.
About PomDoctor Ltd.
PomDoctor Ltd. American Depositary Shares represent ownership in PomDoctor Ltd., a leading online medical services platform specializing in chronic disease management in China. The company operates a comprehensive one-stop platform that organically connects patients with doctors, pharmaceutical products, pharmacies, suppliers, and other healthcare participants, enhancing efficiency and transparency in the healthcare value chain. Its primary business segments include the Internet hospital, facilitating virtual consultations and medical services, and the pharmaceutical supply chain, which forms the core of its operations. PomDoctor Ltd. focuses on delivering cost-effective, customized healthcare solutions for chronic conditions, fostering a vibrant ecosystem around prevention and treatment. Founded in 2010 and headquartered in Guangzhou, China, it plays a significant role in China's digital healthcare market, particularly in the pharmaceutical retailers industry within the broader healthcare sector.
About Dt Cloud Star Acquisition Co.
Dt Cloud Star Acquisition Co. is a special purpose acquisition company (SPAC) focusing on the technology sector. As a SPAC, its primary function is to raise capital through an initial public offering (IPO) with the goal of acquiring or merging with a target company, typically within a specified timeframe. This approach provides a more streamlined pathway for private companies to access public markets.
Dt Cloud Star Acquisition Co. is strategically positioned to leverage emerging opportunities across the tech industry, potentially focusing on rapidly growing areas such as cloud computing, artificial intelligence, and other digital transformation technologies. By identifying promising tech firms that can benefit from the transition to public markets, the SPAC aims to unlock value and accelerate growth for its acquisition targets.
In the financial market landscape, Dt Cloud Star Acquisition Co. plays a critical role in accelerating the public debut of innovative tech companies that might otherwise face significant hurdles in a traditional IPO process. The company's activities are closely monitored by investors and industry analysts eager to witness its selection and acquisition strategy.
About Barinthus Biotherapeutics Pte Ltd.
Barinthus Biotherapeutics Pte Ltd is a biotechnology company focused on pioneering advancements in biotherapeutic solutions to address unmet medical needs. Specializing in the development of novel therapies, Barinthus Biotherapeutics seeks to innovate beyond traditional biopharmaceuticals, targeting significant disease areas such as oncology and neurology. The company employs cutting-edge research techniques, including gene therapy and regenerative medicine, to develop treatments that may transform patient care and outcomes. As part of the broader biotech sector, Barinthus Biotherapeutics plays an integral role in pushing the boundaries of medical research and development. Its contributions are crucial in driving the biopharmaceutical industry's growth through the discovery and application of new treatment modalities. With a commitment to scientific excellence and patient-focused innovation, Barinthus Biotherapeutics aims to deliver groundbreaking therapies that could redefine standards in medical treatment.
About Planet Green Holdings Corp.
Planet Green Holdings Corp. is a diversified holding company focused on consumer products, tea products, chemical products, and online advertising services. Through its subsidiaries, the company develops, manufactures, and distributes a range of tea offerings, including black, green, and specialty brick teas, while also participating in chemical operations such as fuel additives, formaldehyde-based materials, methylal, and related industrial products. In addition, Planet Green Holdings Corp. provides digital advertising delivery and operational services, and it has expanded into health-related products, including dietary and supplement-related offerings in select markets. The company operates across China, Hong Kong, Canada, and the United States, serving both consumer and industrial customers through a multi-segment business model. Headquartered in Flushing, New York, Planet Green Holdings Corp. is positioned as a small-cap, multi-industry business with activities spanning beverage goods, chemicals, and digital services.
About Liminatus Pharma Inc.
Liminatus Pharma Inc. is a clinical-stage biopharmaceutical company focused on developing cancer therapies with an emphasis on immuno-oncology approaches. The company concentrates on immune-modulating treatments designed to target tumors more precisely by harnessing the body’s own immune system. Liminatus Pharma’s lead work includes a Guanylyl Cyclase C (GCC)–targeted vaccine being evaluated in mid-stage clinical trials for colorectal, pancreatic, gastric, and esophageal cancers that express GCC, addressing tumor types with significant unmet medical need. Its programs are positioned within the broader biotechnology and healthcare sectors, contributing to the oncology treatment landscape through novel therapeutic platforms rather than traditional chemotherapies. Liminatus Pharma Inc. operates today as a specialized innovator in cancer drug development, engaging primarily in research, clinical testing, and related translational activities. Founded in 2020 and headquartered in Cerritos, California, the company plays a focused role in the market as an emerging developer of targeted immuno-oncology candidates.
About Brillia Inc.
Brillia Inc. is a thriving organization in the biotechnology sector, focusing on innovative healthcare solutions. The primary function of this company revolves around the development and commercialization of advanced therapeutic products aimed at treating diverse medical conditions. Known for their cutting-edge research in regenerative medicine and biologic therapies, Brillia Inc. significantly impacts the pharmaceutical and healthcare industries by introducing new methodologies that enhance patient care and treatment outcomes.
Operating at the forefront of medical innovation, Brillia Inc. collaborates with research institutions and clinical experts to ensure the effectiveness and safety of its offerings. This collaborative approach enables the company to navigate regulatory landscapes efficiently and bring groundbreaking treatments to the market promptly. Brillia Inc.'s dedication to improving health outcomes through scientific discovery and its robust pipeline of therapeutic products make it a key player in the biotechnology industry. Its contributions not only advance patient therapy options but also support the broader goals of medical advancement and improved global health standards.
About Cosmos Health Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare group specializing in pharmaceuticals, nutraceuticals, healthcare services, and digital assets. The company engages in the importation, exportation, distribution, and sale of pharmaceutical products, including over-the-counter drugs, branded and generic medicines, vitamins, minerals, dietary supplements, medical devices, and baby products. It manufactures and markets proprietary brands such as Sky Premium Life, NOOR Collagen, C-Sept, C-Scrub antimicrobial cleansers, and Mediterranation, with operations spanning Europe, the United States, the UK, UAE, and other regions. Cosmos Health Inc. operates manufacturing facilities like Cana Laboratories for contract production, distribution networks including CosmoFarm with robotic automation for pharmacy logistics, and telehealth initiatives. It conducts research and development through platforms like Cloudscreen AI for drug repurposing, focusing on nutraceutical formulas, nanotechnology, and compounds targeting obesity and other disorders. Additionally, the company manages a digital asset treasury featuring Bitcoin and Ethereum holdings to diversify its balance sheet. Serving wholesalers, pharmacies, clinics, retailers like Tesco and Superdrug, and healthcare providers, Cosmos Health Inc. supports a broad ecosystem in wellness and medical distribution. Founded in 2009 and headquartered in Thessaloniki, Greece, it plays a key role in bridging manufacturing, innovation, and global supply chains in the healthcare sector.
About Next Technology Holding Inc.
Next Technology Holding Inc. is a Wyoming-incorporated technology company pursuing a dual-engine business model that combines AI-enabled software development services with the acquisition and holding of Bitcoin. It develops and implements SaaS+AI platforms, providing customized monitoring and management systems, along with training and support services, primarily to industrial clients in the Asia-Pacific region, including Hong Kong and Singapore. The company's solutions target specific sectors such as hospitality with AI-enabled security monitoring platforms, water management through smart water-energy synergy systems, and Bitcoin mining via integrated liquid cooling hardware and SaaS group control management. Next Technology Holding Inc. generates revenue from recurring subscription and service fees under commercial customer agreements in these industries. Complementing its software operations, it strategically acquires Bitcoin using excess liquid assets and capital-raising proceeds, viewing it as a long-term store of value. Incorporated in 2019, the company maintains its principal executive offices in Shenzhen, China, positioning it uniquely at the intersection of applied AI software applications and digital asset management within the technology sector.
About Direxion Daily Netflix Bull 2X Shares
Direxion Daily Netflix Bull 2X Shares is a leveraged exchange-traded fund designed to provide investors with twice the daily return of Netflix stock. This unique financial instrument is part of the leveraged ETF category, where it seeks to magnify the performance of Netflix by utilizing financial derivatives and debt to achieve its investment objective. The primary function of this asset is to cater to sophisticated investors looking for amplified short-term movements in Netflix's stock price. It is particularly appealing to those who wish to capitalize on sharp intraday market trends within the media and entertainment industry. As a financial product, Direxion Daily Netflix Bull 2X Shares plays a role in providing liquidity and broader market access, allowing for specialized strategies in portfolio management. Its leveraged nature makes it a significant tool for dynamic trading strategies, typically used for short-term investment horizons due to the inherent volatility and risks associated with leveraged ETFs. This ETF underscores the evolving landscape of financial instruments aimed at providing precise, targeted exposure to high-growth individual stocks.
About Defiance Daily Target 2X Long PURR ETF
Defiance Daily Target 2X Long PURR ETF is an actively managed, leveraged exchange-traded fund designed to provide twice the daily price exposure to Hyperliquid Strategies Inc, a digital asset treasury and investment company focused on the Hyperliquid Layer-1 blockchain ecosystem and its native token, HYPE. The fund targets 200% of the daily percentage change in the share price of Hyperliquid Strategies Inc for a single trading day, giving market participants a concentrated, short-term tool to express bullish views on this HYPE-focused treasury business. To achieve its objective, the ETF primarily uses derivatives such as swap agreements and listed options, rebalancing its positions each day to maintain the intended leverage. Defiance Daily Target 2X Long PURR ETF sits within the trading–leveraged equity segment, serving traders who seek amplified access to the performance of a specialized digital asset treasury company without directly holding HYPE tokens or interacting with the underlying blockchain infrastructure. Founded and launched in the United States, it forms part of Defiance’s broader lineup of thematic, leveraged ETFs targeting specific single-stock exposures in niche, high-growth market segments.
About VCI Global Limited
VCI Global Limited is a holding company that operates as a business and technology consulting and platform development group. Headquartered in Kuala Lumpur, Malaysia and founded in 2013, the company serves clients in Malaysia, China, Singapore, the United States, and other markets. VCI Global Limited provides business strategy consultancy, including listing solutions, investor relations, and boardroom advisory, alongside corporate finance, structuring and restructuring, and merger and acquisition advisory services. The company also delivers technology consultancy encompassing digital development, fintech and software solutions, and digital transformation support. Through its various subsidiaries, VCI Global Limited is active in areas such as artificial intelligence, cybersecurity, fintech, and enterprise software, offering solutions to small and medium-sized enterprises, government-linked entities, and publicly traded conglomerates across diverse industries. This combination of consulting capabilities and technology-focused platforms positions VCI Global Limited as a participant at the intersection of capital markets, digital infrastructure, and enterprise innovation.
About My Size, Inc.
My Size, Inc. is a technology-driven company specializing in the development of mobile applications that enhance the apparel shopping experience. The primary function of its application suite is to provide accurate size measurements for apparel consumers, helping reduce the inefficiency and inconvenience associated with incorrect clothing sizes. This reduces return rates and enhances user satisfaction for e-commerce retailers. My Size’s innovative technology, which leverages proprietary algorithms and smartphone sensors, enables customers to measure themselves and find their true fit in various retailers' size charts. This solution is particularly useful in the fashion and online shopping industries, where proper sizing can often be a significant hurdle. By streamlining the sizing process, My Size, Inc. plays an essential role in e-commerce and retail sectors, contributing to improved operational efficiency and customer engagement. The company’s forward-thinking approach underscores the increasing intersection between technology and everyday consumer activities, aiming to transform how the world shops for clothing.
About Leverage Shares 2X Long GEMI Daily ETF
Leverage Shares 2X Long GEMI Daily ETF is a single-stock leveraged exchange-traded fund designed to deliver amplified exposure to the daily price movements of Gemini Space Station, Inc. common stock. Classified as a 2x leveraged ETF, its primary function is to provide investors with two times (200%) the daily return of the underlying GEMI equity, reflecting both gains and losses at double the magnitude, before fees and expenses. The fund utilizes derivatives and daily rebalancing techniques to achieve this leveraged effect, which means its returns over periods longer than a single day may differ significantly from twice the underlying stock’s performance due to compounding and market volatility.
Targeted toward sophisticated, short-term traders, the ETF offers features such as liquidity, capped losses (limited to the invested amount), and no risk of margin calls, distinguishing it from direct margin trading. With a management fee positioned at the industry low for leveraged single-stock ETFs, the fund plays an active role in the growing ecosystem of products aimed at facilitating dynamic participation in innovative, high-growth sectors. The launch of this ETF marks a notable development in the leveraged trading landscape, particularly for those seeking structured, exchange-traded vehicles to pursue short-term tactical strategies based on Gemini Space Station’s performance.
About Clean Energy Technologies, Inc.
Clean Energy Technologies, Inc. is a forward-thinking company specializing in the development and distribution of advanced energy efficiency and environmentally friendly technologies. Primarily focused on producing clean energy solutions, the company leverages its expertise to provide innovative products like waste heat recovery systems, which enhance energy efficiency and reduce operational costs for industrial clients. These systems are instrumental in capturing unused waste energy and converting it into usable electricity, significantly impacting the energy sector by promoting sustainability. Clean Energy Technologies, Inc. serves a diverse range of industries that include chemical processing, power generation, and heavy manufacturing, sectors that typically produce substantial amounts of waste heat. With its commitment to environmental sustainability, the company plays a crucial role in the global shift toward green energy. Its cutting-edge technologies not only support industries in reducing their carbon footprint but also adhere to rigorous energy compliance standards. By championing clean energy solutions, Clean Energy Technologies, Inc. contributes to the growing demand for sustainable industrial practices and positions itself as an essential player in the renewable energy market.
About Skyline Builders Group Holding Ltd. Class A
Skyline Builders Group Holding Ltd. operates as an exempted limited liability company. It operates business through its subsidiary, Kin Chiu Engineering Limited, which provides construction activities include public civil engineering works, such as road and drainage works in Hong Kong. The company was founded on June 25, 2024 and is headquartered in Hong Kong.
About Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer immunotherapies targeting breast cancer and other HER2/neu-expressing cancers. Its lead product candidate, GP2, is a nine-amino acid peptide derived from the HER2/neu protein, combined with GM-CSF to form GLSI-100, designed to prevent breast cancer recurrences in patients who have undergone surgery and standard treatments like trastuzumab. The company is advancing GLSI-100 through the Flamingo-01 Phase III clinical trial, a global, randomized, double-blinded study enrolling up to 750 high-risk HER2-positive patients across approximately 150 sites in the United States and Europe, in collaboration with leading oncology networks and institutions. This immunotherapy aims to activate the immune system against HER2/neu-expressing tumor cells, addressing an unmet need in preventing recurrence for patients where existing therapies fall short. Founded in 2006 and headquartered in Stafford, Texas, Greenwich LifeSciences Inc. operates in the biotechnology sector, emphasizing peptide-based vaccines for oncology applications.
About Intuitive Surgical Inc.
Intuitive Surgical Inc. is a medical technology company focused on robotic-assisted and minimally invasive care. Intuitive Surgical develops, manufactures, and markets the da Vinci surgical systems, which are used by surgeons to perform procedures with enhanced precision through a minimally invasive approach. The company also offers the Ion endoluminal system, extending its platform into diagnostic endoluminal procedures and lung biopsy applications. In addition to its core systems, Intuitive Surgical supports hospitals and healthcare providers with instruments, accessories, and services that help integrate robotic surgery into clinical workflows. Its products serve a broad range of specialties, including general surgery, urology, gynecology, thoracic surgery, and diagnostic care. Headquartered in Sunnyvale, California, Intuitive Surgical plays a significant role in the global healthcare equipment market by advancing the adoption of robotic systems in modern surgical and diagnostic settings.
About Euda Health Holdings Ltd.
Euda Health Holdings Limited is a non-invasive healthcare provider operating across Singapore, Malaysia, and China, with headquarters in Singapore. The company operates through two primary segments: medical services and property management. In healthcare, Euda offers specialty care services through medical facility clinics providing holistic treatment for various illnesses, alongside science-backed wellness solutions including stem cell therapies, immune therapies, bioenergy cabin licensing, molecular supplements, and wellness membership programs. The company positions itself as a next-generation health technology provider focused on longevity and regenerative medicine, emphasizing accessibility and affordability of advanced treatments. In parallel, Euda manages properties including shopping malls, office buildings, residential apartments, and condominiums, providing property management and security services to tenants and owners. Listed on NASDAQ, the company integrates digital healthcare ecosystem capabilities while maintaining its diversified revenue base across both healthcare and real estate segments.
About Armlogi Holding Corp.
Armlogi Holding Corp. is a prominent entity in the logistics and transportation sector. Known for its comprehensive supply chain solutions, the company provides an array of services including freight forwarding, warehousing, and distribution. Its primary function is to streamline the movement of goods and commodities across various regions, ensuring efficiency and reliability for both individual and corporate clients. Armlogi Holding Corp. plays a pivotal role in supporting industries such as retail, manufacturing, and e-commerce, enhancing their logistics operations through innovative technology and strategic partnerships. With a global network of facilities and a commitment to sustainability, the company helps minimize environmental impact while maximizing operational efficiency. This positioning makes Armlogi a critical player in the logistics market, as it continuously adapts to the evolving demands of global trade and consumer expectations. Through its extensive service offerings, Armlogi Holding Corp. significantly influences the supply chain landscape, providing integrated solutions that enhance the economic dynamics of the markets it serves.
About Marwynn Holdings Inc.
Marwynn Holdings Inc. is a prominent company operating in the diversified financial services industry. The primary function of the company is to manage a portfolio of various investments, including but not limited to real estate, equities, and fixed income securities. As a holding company, it primarily aims to generate returns by strategically acquiring and managing its subsidiaries across multiple sectors such as finance, insurance, and energy. Marwynn Holdings Inc. is known for its prudent investment strategies and efficient capital allocation, impacting industries such as real estate development, insurance underwriting, and renewable energy production. Its significance in the financial market stems from its ability to provide investors with exposure to a broad range of industries while benefitting from the strategic oversight and governance. This makes Marwynn Holdings Inc. a key player in offering diversified investment opportunities and contributing to market stability through its robust asset management practices.
About Actuate Therapeutics Inc.
Actuate Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for high-impact, difficult-to-treat cancers through inhibition of glycogen synthase kinase-3, particularly the GSK-3β isoform. Its lead investigational drug, elraglusib, is a small-molecule inhibitor designed to block GSK-3β function within cancer cells, targeting key signaling pathways like NF-κB that promote tumor survival, growth, migration, invasion, and resistance to chemotherapy while enhancing anti-tumor immunity. Elraglusib is under evaluation in Phase 2 trials for metastatic pancreatic ductal adenocarcinoma, with Orphan Drug and Fast Track Designations, and in Phase 1/2 trials for refractory pediatric malignancies such as Ewing sarcoma and neuroblastoma, as well as metastatic melanoma and colorectal cancer. The company also pursues an oral formulation of elraglusib, completing Phase 1 in healthy volunteers and planning further studies in advanced cancers. Actuate Therapeutics Inc. operates in the biotechnology sector, addressing unmet needs in oncology for solid tumors and hematologic malignancies. Founded in 2015 and headquartered in Fort Worth, Texas, it maintains a strategic pipeline aimed at GSK-3β associated diseases.
About Nip Group Inc.
Nip Group Inc. is a specialized insurance and risk management solutions company, primarily focused on serving high-growth industry sectors. The firm provides niche insurance products tailored to meet the specific needs of industries such as landscaping, tree care, and snow removal, as well as social services, real estate investors, and artisan contractors. Nip Group Inc. distinguishes itself by offering customized coverage options and risk management services designed to help businesses in these sectors effectively safeguard their operations against potential liabilities and unforeseen events. By addressing the unique challenges faced by these industries, Nip Group Inc. plays a pivotal role in ensuring business continuity and stability. It contributes significantly to the insurance market by pioneering specialized underwriting practices tailored to emerging business environments. This strategic approach not only solidifies its role in the insurance landscape but also underscores its importance in supporting industry-specific growth and resilience.
About Freight Technologies Inc.
Freight Technologies Inc. is a transportation logistics technology company focused on optimizing cross-border and domestic freight movements in North America. The firm develops and operates a cloud-based logistics management platform that connects shippers, carriers, and intermediaries involved in land-based logistics, with particular emphasis on the U.S.–Mexico–Canada corridor. Its core offering, the Fr8App platform, provides tools for freight matching, route optimization, real-time shipment visibility, and digital document handling, helping streamline operations for logistics stakeholders. Freight Technologies also supports cross-border shipping requirements such as customs-related documentation and compliance, aiming to reduce friction in international freight flows. By leveraging AI-enabled capabilities for carrier matching, pricing, and tracking, the company serves freight agencies, brokers, and transport operators seeking more efficient and data-driven logistics solutions. Founded in 2015 and headquartered in The Woodlands, Texas, Freight Technologies plays a specialized role within the freight technology and digital logistics ecosystem in North America.
About Mannatech, Incorporated
Mannatech, Incorporated is a global health and wellness company that develops, markets, and distributes nutritional supplements, topical and skin care products, as well as weight-management solutions. The firm's core objective is to improve health and wellness through scientifically validated ingredients and formulas. Central to Mannatech's offerings are glyconutrient products, designed to support cellular communication within the body. Operating primarily in the multilevel marketing sector, it expands its reach by establishing direct sales channels across numerous international markets. Headquartered in Flower Mound, Texas, the company plays a significant role in the growing nutraceutical industry, meeting the increasing consumer demand for personalized health and wellness products. By leveraging cutting-edge research and development, Mannatech has positioned itself as a significant player in the global shift towards natural and holistic health solutions. With a focus on innovative product development and strategic market positioning, Mannatech addresses the needs of its diverse customer base, contributing to the broader trends in consumer healthcare and wellness products globally.
About Picard Medical, Inc.
Picard Medical, Inc. is a healthcare equipment company specializing in the development, manufacturing, and commercialization of advanced medical device solutions, with a primary focus on cardiac care. Its core product is the implantable SynCardia Total Artificial Heart, which is designed to temporarily replace the full function of a human heart in patients suffering from end-stage heart failure. This total artificial heart is the only system of its kind approved by both the U.S. Food and Drug Administration and Health Canada, and it is recognized globally as the most widely used and clinically studied artificial heart technology. Over 2,100 SynCardia systems have been implanted across 27 countries, serving as a critical bridge to heart transplantation for those with severe biventricular failure. As the parent company of SynCardia Systems, LLC, Picard Medical, Inc. plays a vital role in advancing life-saving cardiac technologies and addressing the needs of patients with advanced heart disease. Its innovative products underpin its significance within the medical devices sector, contributing to major advancements in artificial organ technology and modern cardiovascular treatment.
About GraniteShares 2x Long MARA ETF
The GraniteShares 2x Long MARA ETF is a leveraged exchange-traded fund designed to provide double the daily return of its benchmark index, which consists of the performance of Marathon Digital Holdings, Inc., a cryptocurrency mining company. The primary function of this ETF is to allow investors to gain amplified exposure to the price movements of Marathon Digital without directly investing in the company's shares. It is highly suitable for short-term traders seeking to capitalize on rapid market changes. This fund actively responds to the volatile nature of the cryptocurrency sector, making it a significant tool for those engaged in speculative trading. As a leveraged ETF, it requires careful attention to market conditions and should be utilized with a clear understanding of the inherent risks due to compounding effects over time. GraniteShares introduces this financial instrument to cater to investors aiming for strategic portfolio maneuvers within the rapidly evolving digital asset space.
About Catheter Precision, Inc.
Catheter Precision, Inc. is a dynamic player in the medical technology sector, specializing in the development and commercialization of advanced catheters and related technologies. The company focuses on providing innovative solutions for electrophysiology, a branch of cardiology that examines and treats arrhythmias. Their products are designed to support physicians in diagnosing and treating heart rhythm disorders with precision and efficacy. Notable features of Catheter Precision’s offerings include cutting-edge technology that enhances the accuracy of cardiac interventions and improves patient outcomes. As part of the broader healthcare sector, the company contributes to advancing medical treatments and has a significant impact on the quality of care provided to patients with cardiac issues. By continually innovating and integrating state-of-the-art technologies, Catheter Precision plays a crucial role in the electrophysiology market, offering tools that empower healthcare professionals to deliver superior cardiac care.
About AIxCrypto Holdings, Inc.
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
About Innventure Inc.
Innventure Inc. is a venture capital firm that focuses on identifying and nurturing breakthrough technological innovations. The primary function of Innventure is to partner with multinational corporations and leverage its unique commercialization strategy to develop early-stage technology ventures into successful businesses. The firm specializes in sectors such as life sciences, advanced materials, and clean technology, thereby influencing the trajectory of these dynamic industries. Innventure's notable feature is its structured approach of working closely with corporate partners to minimize risks and enhance the commercialization prospects of novel technologies. Through its collaborative efforts, Innventure plays a significant role in the financial market by bridging the gap between cutting-edge research and full-scale market deployment, ultimately fueling innovation-driven economic growth.
About Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
About CDT Equity Inc.
Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.
About Direxion Daily HOOD Bull 2X ETF
The Direxion Daily HOOD Bull 2X ETF is a leveraged exchange-traded fund designed to deliver twice (2x) the daily performance of the common shares of Robinhood Markets, Inc. This fund seeks to provide magnified exposure to the short-term movements of Robinhood's stock price, making it a tool primarily for sophisticated traders and market participants who wish to capitalize on anticipated daily gains in Robinhood shares. The ETF employs various financial derivatives to achieve its leveraged objective, resetting its exposure on a daily basis. As with other single-stock leveraged ETFs, this product is intended for short-term tactical trading rather than long-term investment, and its returns over periods longer than a single day can differ significantly from twice the return of Robinhood's stock due to the effects of daily compounding. The Direxion Daily HOOD Bull 2X ETF plays a specialized role in the market, catering to active traders seeking amplified exposure to Robinhood Markets, Inc., within a regulated ETF structure.